Io Biotech Inc (IOBT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,016 | -48,638 | -22,421 | -95,491 | -64,158 |
| Depreciation Amortization | 186 | 125 | 61 | 253 | 189 |
| Accounts payable and accrued liabilities | 927 | 877 | 538 | 782 | 1,378 |
| Other Working Capital | -3,959 | -1,211 | -2,551 | 2,180 | -3,008 |
| Other Operating Activity | -1,509 | 5,954 | 1,302 | 9,929 | 2,877 |
| Operating Cash Flow | $-61,371 | $-42,893 | $-23,071 | $-82,347 | $-62,722 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -58 | -54 | -28 | -44 | -33 |
| Investing Cash Flow | $-58 | $-54 | $-28 | $-44 | $-33 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 26,434 | 11,720 | N/A | N/A | N/A |
| Common Stock Issued | 2 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 6,321 | -233 | 0 | 0 | 0 |
| Financing Cash Flow | $32,757 | $11,487 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | -695 | -440 | 154 | -771 | -253 |
| Beginning Cash Position | 60,299 | 60,299 | 60,299 | 143,461 | 143,461 |
| End Cash Position | 30,932 | 28,399 | 37,354 | 60,299 | 80,453 |
| Net Cash Flow | $-29,367 | $-31,900 | $-22,945 | $-83,162 | $-63,008 |
| Free Cash Flow | |||||
| Operating Cash Flow | -61,371 | -42,893 | -23,071 | -82,347 | -62,722 |
| Capital Expenditure | -58 | -54 | -28 | -44 | -33 |
| Free Cash Flow | -61,429 | -42,947 | -23,099 | -82,391 | -62,755 |